Abstract:Abstract Background: Previous lung cancer models were mostly based on case control studies and used limited epidemiological risk factors. The clinical utility was hampered due to lack of added value beyond smoking history. In this study, we developed a series of lung cancer risk prediction models using extensive data, including lab testing data, from a large prospective cohort in Taiwan. In particular, we developed a risk prediction model within heavy smokers with ≧30 pack years that could further stratify this group and improve the screening efficiency of Low Dose Computed Tomography (LDCT). Methods: The cohort participants were divided into equal training and validation sets, by using variables from personal history and standard lab tests. Cox proportional hazards regression and goodness of fit were used to generate area under the curve (AUC). Results: A total of 1,774 incident lung cancer cases were identified among 505,030 participants recruited in a 14-year period during 1994-2007. We developed a “History only” model that included smoking status, body mass index (BMI), family history, and personal history; a “lab only” model that included blood in sputum, lung function test and serum biomarkers like carcinoembryonic antigen (CEA), bilirubin, and alpha fetoprotein (AFP); and an integrative model with all these variables. The AUC for “history only” model was 0.837, “lab only” model, 0.839, and integrative model, 0.862. We also developed integrative models for ever-smokers and never-smokers with AUCs of 0.872 and 0.801, respectively. Furthermore, since LDCT is recommended for heavy smokers with ≥ 30 smoking pack-years but with a high false positive rate, we developed a risk model in this group to further stratify this group. A total of 454 incident lung cancer cases were identified among 23,582 heavy smokers. Six variables are significantly associated with lung cancer risk: age, smoking status (current or former), smoking intensity (number of packs smoked in a day), BMI, lung function test and CEA. Current smokers, who smoked >1 pack per day, with BMI <25, lowest lung function and highest CEA, had the highest risk. The number of smokers needed to screen to identify one lung cancer (NNS) could decrease to 13 in this high-risk heavy smokers group from 52 in heavy smokers as a whole, a four-fold increase in risk identification. Highest risks were found among smokers with CEA ≧3.8 ug/L (NNS between 13 and 37) and smokers with lung function MMF<43 ml/sec (NNS between 13 and 25). Conclusion: Routinely collected lab data can significantly improve lung cancer risk prediction models. An integrative lung cancer risk prediction model among heavy smokers with ≧30 pack years can stratify subjects with a 3-4 fold difference in lung cancer risk for LDCT screening. The model found decreased lung function and high CEA values, along with detailed smoking history and low BMI, offered a unique predictive ability to improve the efficiency of LDCT screening. Citation Format: Xifeng Wu, Chi Pang Wen, Yuanqing Ye, MinKwang Tsai, Xia Pu, Wong-Ho Chow, Chad Huff, Sonia Cunningham, Maosheng Huang, Shiuan Bei Wu, Chwen Keng Tsao, Jian Gu. The use of lung cancer risk prediction model to stratify heavy smokers: The power of routinely collected lab data. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr LB-298. doi:10.1158/1538-7445.AM2014-LB-298

Applying machine learning to construct an association model for lung cancer and environmental hormone high‐risk factors and nursing assessment reconstruction

A Machine Learning-Based Diagnosis Modelling of Type 2 Diabetes Mellitus with Environmental Metal Exposure

Evaluating county-level lung cancer incidence from environmental radiation exposure, PM2.5, and other exposures with regression and machine learning models

Machine Learning for Early Discrimination Between Lung Cancer and Benign Nodules Using Routine Clinical and Laboratory Data

[Exploratory Research on Developing Lung Cancer Risk Prediction Model in Female Non-Smokers].

Development of Lung Cancer Risk Prediction Machine Learning Models for Equitable Learning Health System: Retrospective Study

Abstract LB-298: the Use of Lung Cancer Risk Prediction Model to Stratify Heavy Smokers: the Power of Routinely Collected Lab Data

Construction of a risk prediction model for lung infection after chemotherapy in lung cancer patients based on the machine learning algorithm

Determining Association between Lung Cancer Mortality Worldwide and Risk Factors Using Fuzzy Inference Modeling and Random Forest Modeling

Pesticides, cancer, and oxidative stress: an application of machine learning to NHANES data

Machine Learning and Real-World Data to Predict Lung Cancer Risk in Routine Care

Assessment of EMR ML Mining Methods for Measuring Association between Metal Mixture and Mortality for Hypertension

Development of an interpretable machine learning model associated with heavy metals’ exposure to identify coronary heart disease among US adults via SHAP: Findings of the US NHANES from 2003 to 2018

Machine learning computational model to predict lung cancer using electronic medical records

Construction and Validation of Early Warning Model of Lung Cancer Based on Machine Learning: A Retrospective Study

Risk prediction model for lung cancer incorporating metabolic markers: Development and internal validation in a Chinese population

Building a predictive model for hypertension related to environmental chemicals using machine learning

Genome-wide Association Study Based Risk Prediction Model in Predicting Lung Cancer Risk in Chinese

Machine learning-aided metallomic profiling in serum and urine of thyroid cancer patients and its environmental implications

Predicting the risk of lung cancer using machine learning: A large study based on UK Biobank